hat
Gwosès Pou US FDA a, liothyronine se kategori kòm Gwosès Kategori A. Òmòn idrolyom a minimal transfere nan fetis la oswa plasenta, sepandan kòm nan mwa Oktòb 2014, syans pa te montre okenn efè negatif nan fetis la. Manman Hypothyroid ta dwe kontinye pran terapi ranplasman òmòn nan tout gwosès pou evite evènman negatif.
eng
Pregnancy Per the U.S. FDA, liothyronine is categorized as Pregnancy Category A.Thyroid hormone is minimally transferred to the fetus or placenta, however as of October 2014, studies have not shown any adverse effects to the fetus. Hypothyroid mothers should continue to take thyroid hormone replacement therapy throughout pregnancy to avoid adverse events.